Connor, Clark & Lunn Investment Management Ltd. Neuronetics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.84 - $4.52 $42,912 - $68,297	-15,110 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$3.87 - $6.59 $18,065 - $30,762	-4,668 Reduced 23.6%	15,110 $67,000
Q3 2021 Nov 12, 2021	BUY	$6.22 - $15.54 $123,019 - $307,350	19,778 New	19,778 $130,000

Others Institutions Holding STIM

# of Institutions

Shares Held

13.1M

Call Options Held

30.1K

Put Options Held

Kent Lake Pr LLC Anasco, PR

2.08M
Shares

$3.14 Million
0.63% of portfolio
Kent Lake Capital LLC Mill Valley, CA

1.74M
Shares

$2.62 Million
1.44% of portfolio
Cannell Capital LLC Alta, WY

1.31M
Shares

$1.98 Million
0.23% of portfolio
Vanguard Group Inc Valley Forge, PA

1.3M
Shares

$1.96 Million
0.0% of portfolio
Masters Capital Management LLC Atlanta, GA

1.2M
Shares

$1.81 Million
0.05% of portfolio

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $40.8M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account